You are here

  • Home
  • Archive
  • Volume 8, Issue 1
  • Elective surfactant increased median duration of mechanical ventilation in preterm infants with mild to moderate respiratory distress syndrome

Article Text

Article menu

Download PDFPDF

Treatment
Elective surfactant increased median duration of mechanical ventilation in preterm infants with mild to moderate respiratory distress syndrome

https://doi.org/10.1136/ebn.8.1.9

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Escobedo MB, Gunkel JH, Kennedy KA, et al. Early surfactant for neonates with mild to moderate respiratory distress syndrome: a multicenter, randomized trial. J Pediatr 2004;144:804–8.OpenUrlPubMedWeb of Science

    Q What is the efficacy of elective brief intubation for early single dose surfactant administration compared with administration as clinically indicated for preterm infants with mild to moderate respiratory distress syndrome (RDS) not requiring mechanical ventilation?

    METHODS

    Embedded ImageDesign:

    randomised controlled trial.

    Embedded ImageAllocation:

    concealed.

    Embedded ImageBlinding:

    unclear if blinded.

    Embedded ImageFollow up period:

    up to discharge from hospital.

    Embedded ImageSetting:

    5 centres in Texas, USA.

    Embedded ImagePatients:

    136 infants with birth weights ⩾1250 g, gestational age ⩽36 completed weeks, postnatal age 4–24 hours, FIO2⩾0.40 with or without nasal continuous positive airway pressure (CPAP), RDS (based on chest radiograph and clinical presentation), no requirement for mechanical ventilation, no previous treatment with surfactant, no known cardiac or respiratory related congenital anomalies, and no anomalies …

    View Full Text

    Footnotes

    • For correspondence: Professor M B Escobedo, Department of Pediatrics, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA. marilyn-escobedoouhsc.edu

    • Source of funding: in part, Abbott Laboratories.